Q2 FY2026 EarningsCRIS missed Q2 FY26 revenue and EPS consensus significantly, reporting zero revenue vs. $0.75M expected following the divestiture of Erivedge. Diluted GAAP EPS was -$4.02, appearing to beat the -$7.11 consensus, but this was primarily driven by a 238% YoY increase in weighted average shares due to massive dilution. Management issued a 'going concern' warning, noting that current cash plus August 2026 offering proceeds will only fund operations into Q4 2026, posing extreme liquidity risk.